fda warning peptides bpc 157 not approved safety concerns The Human Lab Rats Injecting Themselves with | Office for Science and Society Peptides in the Limelight: US

The BPC-157 peptide has three features that distinguish it in preclinical research: its natural gastric origin (making it uniquely stable in biological environments), its dual-pathway mechanism (VEGFR2 angiogenesis and NO modulation simultaneously), and its documented activity across nine distinct tissue systems

For the individual mechanisms, see GHK-Cu for Skin and Hair Research , What Is BPC-157

The most common side effects of receiving VITNEURIN Injection are skin irritation and/or pain around the area of injection, bruising around the injection site, mild nausea, vomiting, abdominal pain or loss of appetite, headache or sleepiness, numbness in the hands or feet, clumsiness or difficulty walking, hives, heartburn, fatigue, and a sore throat

Without the preservative, every time you puncture the stopper, you risk introducing contaminants